Evidence map›Paper›PMID 30912457›Full record

ReviewRenal failure2019

Kimura's disease with membranoproliferative glomerulonephritis: a case report with literature review.

Sensen Su, Xin Chen, Jia Li, Jinyu Yu, Li Zhang

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Renal failure, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Kimura Disease Associated with Minimal Change DiseaseTurkish journal of haematology : official journal of Turkish Society of Haematology · 2021
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Sensen Sua Department of Nephrology , the First Hospital of Jilin University , Changchun , China.
Xin Chenb Department of Digestive Endoscopy , the Second Hospital of Jilin University , Changchun , China.
Jia Lia Department of Nephrology , the First Hospital of Jilin University , Changchun , China.
Jinyu Yua Department of Nephrology , the First Hospital of Jilin University , Changchun , China.
Li Zhanga Department of Nephrology , the First Hospital of Jilin University , Changchun , China.
First Hospital of Jilin University · CNJilin University · CNSecond Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKimura's disease is a rare disease and its etiology is still unclear. Here we reported a case with lymphadenopathy complicated with secondary membranoproliferative glomerulonephritis. CASE PRESENTATION: A 46-year-old Chinese man presented with bilateral tumor-like nodules over his neck during the past 6 months and developed edema for 15 days. His blood pressure was 145/90 mmHg, multiple 1 × 1 cm masses were found over bilateral post-auricular and submandibular areas, along with trace edema of the lower extremities. Laboratory data showed an increased peripheral eosinophil count at 3.66 × 10

conclusionKimura's disease can present with bilateral neck nodules and nephrotic syndrome (membranoproliferative glomerulonephritis), and prednisone can be a suitable choice of treatment.

Indexed as

Angiolymphoid Hyperplasia with EosinophiliaBiopsyGlomerulonephritis, MembranoproliferativeGlucocorticoidsHumansKidneyLymph NodesMaleMiddle AgedPrednisoneRare DiseasesTreatment OutcomeGlucocorticoidsPrednisoneKimura's diseasemembranoproliferative glomerulonephritisnephrotic syndromeprednisone

Identifiers

PMID30912457
PMCPMC6442089
OpenAlexW2924353722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.